Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2481352 | European Journal of Pharmaceutical Sciences | 2011 | 5 Pages |
Abstract
Multidrug resistance of bacterial pathogens is a major problem and there is a clear need for the development of new types of antibiotics. Here we investigated the antimicrobial activity of ruthenium(II) based DNA-intercalating complexes. These complexes were found to have no activity in vitro against the Gram-negative bacterium Escherichia coli, but the complexes were clearly active against the Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus. In vivo activity has also been demonstrated for one of the compounds using a simple infection model, the nematode Caenorhabditis elegans. Importantly, this also showed that the compound tested was not toxic to the nematodes.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Albert Bolhuis, Lorna Hand, Julia E. Marshall, Adair D. Richards, Alison Rodger, Janice Aldrich-Wright,